Daniel Vitor de Souza, Barbara Dos Anjos Rosario, Lorrany Da Silva Avanci, Gabriel Carvalhal de Aguiar, Viviane Carlin, Milena De Barros Viana, Daniel Araki Ribeiro
{"title":"Exposure to crack cocaine induces genotoxicity and degenerative changes in multiple organs of Wistar rats.","authors":"Daniel Vitor de Souza, Barbara Dos Anjos Rosario, Lorrany Da Silva Avanci, Gabriel Carvalhal de Aguiar, Viviane Carlin, Milena De Barros Viana, Daniel Araki Ribeiro","doi":"10.1080/00498254.2025.2522737","DOIUrl":null,"url":null,"abstract":"<p><p>Crack cocaine is a widely consumed illicit substance worldwide. Recent studies identify Brazil as the largest consumer of crack cocaine. This study evaluated its harmful effects on various organs in rats. Twenty-four male Wistar rats were distributed into four groups: G1 - exposed to 25 mg of crack cocaine; G2 - 50 mg; G3 - 100 mg; and a control group with no intervention. The experimental groups inhaled crack cocaine smoke once daily for five days. Histopathological changes were observed in the liver of G3 and in the kidneys of all exposed groups. Increased 8-OHdG immunoexpression occurred in the kidneys of G1 and G2. Ki-67 immunoexpression in the liver and kidneys was elevated in G1 and G2. GST-P-positive foci increased in G1 and G2. Micronucleated cells in bone marrow were significantly higher in all exposed groups. In the liver, hepatocytes with micronuclei increased in G1 and G2, while binucleated cells were more frequent in G3. Karyolysis increased in G2 and G3, and karyorrhectic hepatocytes were more frequent in G1 and G2. These findings demonstrate that inhalation exposure to crack cocaine induces degenerative and genotoxic effects in the liver, kidneys, and bone marrow of Wistar rats. These results offer new insights into the carcinogenic potential of crack cocaine in multiple organs, underscoring the need for public health interventions among its users.</p>","PeriodicalId":23812,"journal":{"name":"Xenobiotica","volume":" ","pages":"1-20"},"PeriodicalIF":1.3000,"publicationDate":"2025-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Xenobiotica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/00498254.2025.2522737","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Crack cocaine is a widely consumed illicit substance worldwide. Recent studies identify Brazil as the largest consumer of crack cocaine. This study evaluated its harmful effects on various organs in rats. Twenty-four male Wistar rats were distributed into four groups: G1 - exposed to 25 mg of crack cocaine; G2 - 50 mg; G3 - 100 mg; and a control group with no intervention. The experimental groups inhaled crack cocaine smoke once daily for five days. Histopathological changes were observed in the liver of G3 and in the kidneys of all exposed groups. Increased 8-OHdG immunoexpression occurred in the kidneys of G1 and G2. Ki-67 immunoexpression in the liver and kidneys was elevated in G1 and G2. GST-P-positive foci increased in G1 and G2. Micronucleated cells in bone marrow were significantly higher in all exposed groups. In the liver, hepatocytes with micronuclei increased in G1 and G2, while binucleated cells were more frequent in G3. Karyolysis increased in G2 and G3, and karyorrhectic hepatocytes were more frequent in G1 and G2. These findings demonstrate that inhalation exposure to crack cocaine induces degenerative and genotoxic effects in the liver, kidneys, and bone marrow of Wistar rats. These results offer new insights into the carcinogenic potential of crack cocaine in multiple organs, underscoring the need for public health interventions among its users.
期刊介绍:
Xenobiotica covers seven main areas, including:General Xenobiochemistry, including in vitro studies concerned with the metabolism, disposition and excretion of drugs, and other xenobiotics, as well as the structure, function and regulation of associated enzymesClinical Pharmacokinetics and Metabolism, covering the pharmacokinetics and absorption, distribution, metabolism and excretion of drugs and other xenobiotics in manAnimal Pharmacokinetics and Metabolism, covering the pharmacokinetics, and absorption, distribution, metabolism and excretion of drugs and other xenobiotics in animalsPharmacogenetics, defined as the identification and functional characterisation of polymorphic genes that encode xenobiotic metabolising enzymes and transporters that may result in altered enzymatic, cellular and clinical responses to xenobioticsMolecular Toxicology, concerning the mechanisms of toxicity and the study of toxicology of xenobiotics at the molecular levelXenobiotic Transporters, concerned with all aspects of the carrier proteins involved in the movement of xenobiotics into and out of cells, and their impact on pharmacokinetic behaviour in animals and manTopics in Xenobiochemistry, in the form of reviews and commentaries are primarily intended to be a critical analysis of the issue, wherein the author offers opinions on the relevance of data or of a particular experimental approach or methodology